Landscapes / Targets
FZD4
1 drug acts on FZD4, in 3 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs1
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Multi-specific immunoglobulin |
Phase 2/3 | 11 Jan 2027Phase 2/3 trial completes | |||
| How it works | An antibody built to latch onto two or more targets at once | ||||
| Next date | 11 Jan 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (NVAMD) and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 1 of 1 drug. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026